4Life Transfer Factor® Tri Factor® Formula is now included in the 2011 Physicians’ Desk Reference (PDR). This prestigious book is the standard guide for close to half a million medical professionals throughout the United States. We’ve answered a few commonly asked questions about 4Life’s inclusion in the PDR to help you better understand the importance of this publication and utilize it to your business advantage.
4life in pdr

What is the Physicians’ Desk Reference?

The PDR is the go-to reference guide for hundreds of thousands of medical professionals across the United States. This book is the single source for information about drugs, supplements, and herbs on the market today. It also provides important technical information on breakthroughs in treatments, anti-aging science, scientific studies, nutrition, and much more.

How many years has the PDR been in circulation?

The PDR has been in publication for more than 60 years.

How many doctor’s offices have the PDR?

Today, the PDR can be found in virtually every physician’s office, hospital, and pharmacy in the United States. It’s mailed to 475,000 medical offices! In fact, nine out of ten doctors consider the PDR their most important reference source for drug and treatment information.

How many years have 4Life products been featured in the PDR?

Beginning in 2003, 4Life Transfer Factor products have been included in the Physicians’ Desk Reference for Nonprescription Drugs, Dietary Supplements, and Herbs. This year, 4Life Transfer Factor Tri-Factor Formula is included in the main PDR that is distributed to doctors, hospitals, and medical professionals throughout the United States.

What is included in the 2011 4Life listing?

The 2011 4Life Transfer Factor® Tri-Factor® Formula PDR listing includes an in-depth definition and history of transfer factors, plus significant research milestones. It also provides important product information about 4Life Transfer Factor Tri-Factor Formula, lists a number of 4Life Transfer Factor products, and includes synopses on several clinical studies.

How does the PDR increase credibility for 4Life business builders?

For more than a decade, 4Life has proved its unwavering commitment to manufacturing high-quality, scientifically-based, and effective products. 4Life has a long history of inclusion in the Physicians’ Desk Reference for Nonprescription Drugs, Dietary Supplements, and Herbs.

This new listing in the main PDR further underscores 4Life’s superior reputation in the supplement industry and our dedication to products that are backed by sound scientific research. It also strengthens your position as an exclusive leader in the distribution of 4Life Transfer Factor products. Utilize it the next time you contact a medical professional about our products!

“I want to thank 4Life, and especially the Research and Development department, for listing our products in the PDR. The credibility it gives our products is immeasurable! I am beyond excited!”

Cynthia Champion-Olson, ND
Naturopathy and Clinical Nutrition
Health Sciences Advisory Board Member

“With the 4Life Transfer Factor Tri-Factor Formula listing in the traditional PDR, distributors and customers can now direct their physician and health practitioner to it for a more comprehensive read on the structure, function, safety, and research of transfer factors. Thank you, Dr. McCausland and the 4Life Research and Development department, for making this happen! This will definitely have a positive impact on distributor efforts to educate medical practitioners about 4Life Transfer Factor.”

Suzette Lawrence, MSN, CNM
Autism Spectrum Disorders
Health Sciences Advisory Board Member

Patent protection empowers 4Life distributors with exclusivity and credibility in the marketplace. 4Life recently announced that the United States Patent & Trademark Office (USPTO) has awarded the company a composition patent (U.S. Patent #7,815,943) that protects the 4Life Transfer Factor® Cardio formula through 2025. This is our ninth worldwide patent. We also have dozens of pending patent applications.

4Life’s Health Sciences Advisory Board is made up of physicians, scientists, nutritionists, immunologists, and researchers. These men and women are proud to represent 4Life products and educate others on their benefits, scientific research, and unlimited possibilities.

Descriptors such as unique and exclusive perfectly define 4Life’s product line. And 4Life isn’t a company to rest on its laurels. You can be confident that our in-house Research and Development department is working every day to search for new ways to help 4Life stay at the forefront of immune system support products.

Salt Lake City, Utah (June 6, 2011)

This past weekend, over 10,000 4Life distributors converged in Bogotá for the International Networkers Team (INT) Convention, Equipo Con Identidad. In support of INT, 4Life Founders David and Bianca Lisonbee and President Steve Tew and his wife Sherma traveled to Colombia with a group of twenty corporate representatives.

Event highlights included a celebration of record sales growth and rank advancements with presentations by Platinum International Diamonds Dr. Herminio Nevárez and Yadira Olivo, Juan Rosado and Damaris Zapata, and the pinning of 4Life’s newest Platinum International Diamonds Ángel Molina and Ivelisse López of Puerto Rico.

During the event, 4Life Founders David and Bianca Lisonbee shared their vision of business, service, and family. President Steve Tew staged a State of the Company address with Chief Operations Officer Danny Lee, Senior Vice President, International Jeff Kalinin, General Manager of Spain and Portugal Rafael Fernández, and Director of Field Development, Spanish Markets Deborah Dixon.

Senior VP, International Jeff Kalinin: “This show was filled with passion, power, and energy. The commitment of our 4Life INT distributors is a great testament to the value we offer as a company and the benefits of being part of a strong team.”

Dr. Herminio Nevárez and Yadira Olivo staged the 2011 International Networkers Team event in Bogotá because Colombia distributors accounted for the largest mobilization of people from all countries at last year’s INT event, which took place in Panama.

President Steve Tew: “Platinum International Diamond Dr. Hermino Nevárez and his entire team share a clear and strong vision of the future. They are committed to turning dreams into reality and have proven time and again that they know how.”

4Life has offices on five continents to service a global network of independent distributors through science, success, and service.

For more information:
Calvin Jolley
Vice President, Communications
4Life Research USA, LLC
CalvinJolley@4life.com

Salt Lake City, Utah (April 11, 2011)

4Life Research™ is proud to announce Ángel Molina and Ivelisse López of Puerto Rico as the newest Platinum International Diamonds, the highest rank of achievement in the company.

Prior to 4Life, Ángel worked a variety of different jobs, but none provided his family with the security he desired. In 2002, Ángel and Ivelisse began their 4Life home-based business. Their experience was similar to many distributors: they started slow and struggled with a variety of challenges.

“After a year, I became discouraged because my business wasn’t growing and I wasn’t getting anywhere,” says Ángel. “But I never lost sight of what was possible, and along the way I learned that I could succeed with the support of mentors. I thank God and Platinum International Diamonds Dr. Herminio Nevárez and Juan Rosado. Without them, it would have been impossible for us to succeed in this business.”

Vice President of Field Development Mark Petersen: “Like true leaders, Ángel and Ivelisse attribute their success to others around them. Their example teaches us that it is never too late to start.”

Ángel and Ivelisse have four children: eighteen-year-old Merari Molina Albaladejo; fifteen-year-old Anfernee Molina Albaladejo; five-year-old Ángel J. Molina López, and one-year-old Gabriela A. Molina López.

President Steve Tew: “Ángel and Ivelisse enjoy the distinction of becoming 4Life’s eighth Platinum International Diamonds. Their success is an inspiration because it represents the sum total of challenges they’ve overcome.”

Founder and CEO David Lisonbee: “Ángel and Ivelisse personify our mission of Together, Building People®. Their example shows us that in many ways, true success comes when we place ourselves in the service of others.”

4Life has offices on five continents to service a global network of independent distributors through science, success, and service.

For more information:
Calvin Jolley
Vice President, Communications
4Life Research USA, LLC
CalvinJolley@4life.com

Salt Lake City, Utah (April 28, 2011)

President Steve Tew has announced that sales are at an all time record high, with worldwide sales up more than 20%.

Steve Tew: “In our industry, there’s no clearer evidence of growth than rank advancement. Throughout the recession, 4Life distributors maintained momentum by refusing to allow difficult circumstances to limit their success. As a result, sales are up 20% worldwide. The month of March exceeded any previous month by millions of dollars.”

In the month of March, 4Life enjoyed a number of top-tier rank advancements, including Ángel Molina and Ivelisse López of Puerto Rico, the company’s eighth Platinum International Diamonds, as well as Oyunmaa Banzragch, the company’s first Gold International Diamond from Mongolia and Jhonny Aguilar Pinto and Betzaida Cova de Aguilar, the company’s first Gold International Diamonds from Venezuela.

In addition, Dionny Recio became the second Gold International Diamond in the Dominican Republic and Juan Vargas and Heidy Rosado became the company’s nineteenth current Gold International Diamonds in the United States.

During the last thirteen years, 4Life has established itself as a world leader in direct sales. In 2003, Inc. 500 recognized 4Life as the fifteenth fastest growing privately-held company in the United States. This year, Direct Selling News will name 4Life among the top 100 global direct selling companies in the world.

David Lisonbee, Founder and CEO: “When Bianca and I launched 4Life in 1998, we were committed to Taking Transfer Factor to the World®. Since that time, 4Life distributors have done just that. Today, our global corporate team is committed to empowering distributors as they continue to share our products, opportunity, and philanthropic mission.”

4Life has offices on five continents to service a global network of independent distributors through science, success, and service.

For more information:
Calvin Jolley
Vice President, Communications
4Life Research USA, LLC
CalvinJolley@4life.com

Salt Lake City, Utah (January 3, 2011) 4Life Research™ announced today that the United States Patent & Trademark Office (USPTO) has awarded the company a composition patent that protects the 4Life Transfer Factor® Cardio formula until 2025. This is the company’s sixth worldwide patent. 4Life has numerous international patents and dozens of patent applications pending.

4Life’s progressive science and pursuit of patent protection strengthens the business opportunity for 4Life distributors with the exclusive” right to market 4Life Transfer Factor® products. 4Life President Steve Tew: “We invest a great deal of resources into patent protection on behalf of our distributors because we know that the opportunity they share must accompany the kind of exclusivity, credibility, and longevity that patents exist to provide.”

4Life’s commitment to patents includes an emphasis on research and development to generate formulas, compositions, and processes that are patentable. While 4Life’s legal team concentrates on patent acquisition, the International Product Registration department focuses on registrations around the world to support distributor growth now and in the future. In 2010, 4Life completed 101 product registrations in 30 countries.

4Life Founder and CEO David Lisonbee: “Patent protection is just one way that we work to empower 4Life distributors with exclusivity and credibility in the marketplace. 4Life patents provide our distributors with security for decades to come.

4Life has offices on five continents to serve a global network of independent distributors through science, success, and service.

4Life Transfer Factor Cardio brings together powerful and proven ingredients to help support the entire cardiovascular system, beginning with the immune support of Targeted Transfer Factor.

While studying tuberculosis in the late 1940s, Dr. H. Sherwood Lawrence discovered that the immune competence of a donor could be transferred to a naive recipient by using low molecular weight extracts obtained from white blood cells. Dr. Lawrence called these small molecule extracts transfer factor (TF). If the thymus gland can be compared to grammar school and prep school, transfer factor can be compared to collegiate and graduate level training for the immune system. Scientists later found transfer factors to be universally effective, regardless of the differences between the species of the donor and recipient. This aspect of transfer factors is partly explained by this core scientific belief: the more essential a material or structure is to living organisms, the more common it is to see this material or structure throughout living systems. Transfer factors are essential components of even the most primitive immune systems.

One basic principle of the immune system is that it must be able to respond quickly and specifically, while not exhausting itself by over responding and attacking normal tissue. Transfer factor preparations consist of three identifiable fractions named by their discovered effects on the immune system. They are inducer, antigen specific and suppressor fractions. More recent understanding of immune function would rename the suppressor fraction as the regulator factor. The TF inducer fraction triggers a general state of readiness in the immune system. The antigen-speific fraction is an array of critical tags used by the immune system to identify a host of enemy microbes. Meanwhile, the regulator fraction keeps the immune system from focusing all its strength on a defeated infection and ignoring new microbial threats; it is responsible for controlling immune overreactions that can cause autoimmune disorders. Each fraction (inducer, antigen specific, and regulator) improves one or more aspects of the adaptive ability of the immune system.

Read more: ARTICLES NATCH

Dr. Sherwood Lawrence, who was known as Jerry, was also an expert in infectious diseases, and his research generated other advances in immunology. Dr. Lawrence conducted research on the way the body rejects transplanted organs and how various conditions can damage tissue.

Dr. Lawrence was best known for his discovery, in 1949, of a substance known as ”transfer factor,” a product of T-lymphocytes, which play crucial roles in defending against a wide variety of infectious agents.

He named the product after showing that the type of immune response that lymphocytes could transfer to nonimmune animals could sometimes be transferred to enhance the body’s defenses.

Transfer factor is a small molecule, and it has been the center of scientific mystery, in part because Dr. Lawrence and other scientists were unable to identify it precisely. Some scientists suspect that transfer factor represents bits of many molecules.

”Although there was significant controversy surrounding transfer factor, Jerry doggedly pursued the concept of immune reconstitution that has become a very important field of immunology,” said Dr. Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases.

Dr. Lawrence predicted many aspects of the functioning of lymphocytes and immune cells, and his work provided clues to the later discovery of immune substances known as cytokines.

Dr. Lawrence also identified a link between the way cells respond immunologically to microbes like the bacterium that causes tuberculosis and the type of immune responses involved in the rejection of transplanted organs, said Dr. Fred T. Valentine, an immunologist who worked with Dr. Lawrence at N.Y.U.

Henry Sherwood Lawrence was born in Astoria, Queens. He graduated from New York University in 1938 and its medical school in 1943.

After a year’s internship, Dr. Lawrence served in the Navy in World War II as a medical officer aboard a number of ships. He participated in the Normandy invasion at Omaha Beach and in the invasions of southern France and Okinawa, Japan, and received Bronze Stars in each.

After the war, he completed his training as a specialist in internal medicine at New York University and joined its medical faculty in 1949.

In 1959, he became head of infectious diseases and immunology, a position he held until his retirement in 2000. He was co-director of medical services at Bellevue and New York University Hospitals from 1964 to 2000.

Dr. Lawrence was also director of N.Y.U.’s cancer center from 1974 to 1979, and director of its AIDS research center from 1989 to 1994.

Dr. Lawrence was the founding editor of the journal Cellular Immunology and a member of the National Academy of Sciences.

Wikipedia define Transfer factors as “immune molecules that cause antigen-specific cell-mediated immunity, primarily delayed hypersensitivity and the production of lymphokines, as well as binding to the antigens themselves. They have a molecular weight of approximately 5000 Daltons and are composed entirely of amino acids. Transfer factors were discovered by Henry Sherwood Lawrence.”

Transfer Factor molecules are completely unique. They contain information that can be transferred from one immune system to another. That means that your body can borrow the immune education it needs to Recognize, Respond to, and Remember unwanted threats. 4Life Transferceutical™ Products truly provide the ultimate in immune system support.

4Life Transferceutical™ Products are unique, patented and cutting-edge—improve immune system function by up to 437%. A preliminary scientific test suggests that 4Life Transfer Factor® Tri-Factor® Formula strengthens your immune system guard by increasing the number of protective IgA antibodies.

When it comes to immune system research, 4Life took the lead in 1998 and never let go. We’ve created a new category of immune system research called Transferceutical ™Science. Our science is backed up with multiple patents – and studies that show a record-breaking 437% boost in immune cell activity.